Ken Griffin’s Veradermics MANE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$248M Buy
2,048,475
+170,700
+9% +$18.7M 0.03% 491
2026
Q2
$231M Buy
1,877,775
+52,103
+3% +$4.88M 0.03% 490
2026
Q1
$115M Buy
+1,825,672
New +$92.1M 0.02% 724

Other funds holding MANE

Ken Griffin's MANE Position: Q3 2026 in Review

Ken Griffin increased its Veradermics (MANE) stake by 9.1% in Q3 2026, buying an estimated $18.7M and bringing the position to 2,048,475 shares worth $248M. The position accounts for 0.03% of the portfolio, ranked #491.

Ken Griffin first reported a position in MANE in Q1 2026 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

  • Ken Griffin held 2,048,475 shares of Veradermics worth $248M as of Q3 2026.
  • Ken Griffin bought 170,700 Veradermics shares in Q3 2026, an estimated $18.7M.
  • Veradermics made up 0.03% of Ken Griffin's portfolio in Q3 2026, its #491 holding.
  • Ken Griffin first reported a position in Veradermics in Q1 2026 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held Veradermics as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.